Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study

被引：0
|
作者：
Yasushi Goto
Nobuyuki Yamamoto
Elizabeth T. Masters
Hironori Kikkawa
Jack Mardekian
Robin Wiltshire
Kanae Togo
Yuichiro Ohe
机构：
[1] National Cancer Center Hospital,Department of Thoracic Oncology
[2] Wakayama Medical University,Department of Internal Medicine
[3] Health Economics and Outcomes Research,Medical Affairs, Oncology
[4] Pfizer Inc,Oncology Global Medical Affairs
[5] Pfizer Japan Inc,undefined
[6] Statistics,undefined
[7] Pfizer Inc.,undefined
[8] Pfizer Ltd,undefined
[9] Corporate Affairs,undefined
[10] Health and Value,undefined
[11] Pfizer Japan Inc.,undefined
来源：
Advances in Therapy | 2020年 / 37卷
关键词：
Advanced non-small cell lung cancer; Alectinib; Anaplastic lymphoma kinase; Crizotinib; Medical data vision; Tyrosine kinase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3311 / 3323
页数：12
相关论文
共 50 条
  • [31] Treatment patterns, clinical and economic outcomes of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer receiving ceritinib: a retrospective observational claims analysis
    Dalal, Anand A.
    Guerin, Annie
    Mutebi, Alex
    Culver, Kenneth W.
    JOURNAL OF DRUG ASSESSMENT, 2018, 7 (01) : 21 - 27
  • [32] Drug selection for anaplastic lymphoma kinase-positive non-small-cell lung cancer
    Gadgeel, Shirish M.
    LANCET ONCOLOGY, 2016, 17 (12): : 1627 - 1628
  • [33] Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer A Randomized Clinical Trial
    Horn, Leora
    Wang, Ziping
    Wu, Gang
    Poddubskaya, Elena
    Mok, Tony
    Reck, Martin
    Wakelee, Heather
    Chiappori, Alberto A.
    Lee, Dae Ho
    Breder, Valeriy
    Orlov, Sergey
    Cicin, Irfan
    Cheng, Ying
    Liu, Yunpeng
    Fan, Yun
    Whisenant, Jennifer G.
    Zhou, Yi
    Oertel, Vance
    Harrow, Kim
    Liang, Chris
    Mao, Li
    Selvaggi, Giovanni
    Wu, Yi-Long
    JAMA ONCOLOGY, 2021, 7 (11) : 1617 - 1625
  • [34] Efficacy and safety of crizotinib in patients with anaplastic lymphoma kinase-positive stage IV non-small cell lung cancer.
    Din, Ahmed M. Mohi Ei.
    Rasmy, Ayman Ahamd
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] The Percentage of Anaplastic Lymphoma Kinase-Positive Tumor Cells Has Clinical Implications for Patients with Non-Small Cell Lung Cancer
    He, Yuan
    Gong, Rui
    Sun, Li-Yue
    Zhang, Zi-Chen
    Liu, Xiao-Yun
    Shao, Qiong
    Xu, Fei
    Wang, Hai-Yun
    Shao, Jian-Yong
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2019, 23 (08) : 589 - 597
  • [36] Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment
    Zhou, Jianya
    Zheng, Jing
    Zhang, Xiaochen
    Zhao, Jing
    Zhu, Yanping
    Shen, Qian
    Wang, Yuehong
    Sun, Ke
    Zhang, Zeying
    Pan, Zhijie
    Shen, Yihong
    Zhou, Jianying
    BMC CANCER, 2018, 18
  • [37] Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment
    Jianya Zhou
    Jing Zheng
    Xiaochen Zhang
    Jing Zhao
    Yanping Zhu
    Qian Shen
    Yuehong Wang
    Ke Sun
    Zeying Zhang
    Zhijie Pan
    Yihong Shen
    Jianying Zhou
    BMC Cancer, 18
  • [38] A Patient With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer With Development of Leptomeningeal Carcinomatosis While on Targeted Treatment With Crizotinib
    Riess, Jonathan W.
    Nagpal, Seema
    Neal, Joel W.
    Wake, Heather A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (04): : 389 - 394
  • [39] Ceritinib for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer
    Landi, Lorenza
    Cappuzzo, Federico
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (02) : 203 - 214
  • [40] Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
    Talreja, Vikas T.
    Noronha, Vanita
    Joshi, Amit
    Patil, Vijay
    Mahajan, Abhishek
    Prabhash, Kumar
    SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (04) : 211 - +
12345